BioHarvest Sciences Inc. - Common Stock (NQ:BHST)

1.660 -0.100 (-5.68%)

Delayed Quote Updated: 3:13 PM EDT, Oct 29, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about BioHarvest Sciences Inc. - Common Stock

< Previous 1 2 3 Next >

BioHarvest Advances Proprietary Olive Cell Asset to Commercial Readiness, Opening New CDMO Licensing Opportunity

October 13, 2026

Botanical Synthesis™-developed asset has now completed development, commercial-scale manufacturing and the applicable self-affirmed GRAS process and is ready for production...

Via Newsfile

Tate & Lyle and Bioharvest Reach Key Milestone in Next-Generation Sweetener Development Programme

October 08, 2026

Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - October 8, 2026) - Tate & Lyle PLC (Tate & Lyle), a...

Via Newsfile

BioHarvest Sciences Announces Share Repurchase Program

September 29, 2026

Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - September 29, 2026) - BioHarvest Sciences Inc. (NASDAQ: BHST) (TASE: BHST) (FSE:...

Via Newsfile

BioHarvest Advances Botanical Synthesis Leadership as VINIA Daily Chews Unlock More Value from Its First Consumer Product

September 15, 2026

Single-dose VINIA Daily Chews broaden demographics and usage occasions while demonstrating the commercial versatility of Botanical SynthesisFormat expansion shows how...

Via Newsfile

BioHarvest Sciences to Present at the H.C. Wainwright 28th Annual Global Investment Conference

September 14, 2026

Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - September 14, 2026) - BioHarvest Sciences Inc (NASDAQ: BHST) (TASE: BHST) (FSE: 8MV0),...

Via Newsfile

BioHarvest Sciences Registers for Dual Listing on the Tel Aviv Stock Exchange (TASE)

September 03, 2026

Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - September 3, 2026) - BioHarvest Sciences Inc. (NASDAQ: BHST) (FSE: 8MV0), a...

Via Newsfile

Q3 Virtual Investor Summit Presentations Now Available On Demand

August 31, 2026

From Investor Summit Group

Via ACCESS Newswire

Investor Summit | MicroCap Opportunities to Watch - August 26

August 24, 2026

From Investor Summit Group

Via ACCESS Newswire

BioHarvest Sciences (BHST) Q2 2026 Earnings Call Transcript ↗

August 11, 2026

Rakib outlines shift toward CDMO and secures $20M-$30M fragrance contract.

Via The Motley Fool

Topics Earnings

BioHarvest Sciences Q2 Earnings Call Highlights ↗

August 11, 2026

BioHarvest Sciences (NASDAQ:BHST) reported second-quarter 2026 revenue of $8.8 million, up 3.8% from $8.5 million a year earlier, while highlighting its first manufacturing and supply agreement within...

Via MarketBeat

Topics Earnings

BioHarvest Reports Second Quarter 2026 Financial Results and Provides Business Update

August 11, 2026

Secured first ever CDMO Manufacturing Agreement supporting planned 20-ton commercial production program over two years for rare botanical fragrance,...

Via Newsfile

BioHarvest Secures 20-Ton Manufacturing and Supply Agreement for Rare Botanical Luxury Fragrance

August 11, 2026

Exclusive agreement through 2027 and 2028 is estimated to generate $20-$30 million in revenuePositions BioHarvest in sustainable rare luxury...

Via Newsfile

BioHarvest Sciences to Present at the Canaccord Genuity 46th Annual Growth Conference

July 29, 2026

Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - July 29, 2026) - BioHarvest Sciences Inc (NASDAQ: BHST) (FSE: 8MV0), a...

Via Newsfile

BioHarvest Sciences to Report Second Quarter 2026 Financial Results on August 11, 2026

July 28, 2026

Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - July 28, 2026) - BioHarvest Sciences Inc. (NASDAQ: BHST) (FSE: 8MV0) ("BioHarvest" or the...

Via Newsfile

Topics Earnings

BioHarvest Awarded $1.4M Grant from the Israel Innovation Authority to Pioneer AI-Driven Plant-Cell Synthesis

July 15, 2026

Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - July 15, 2026) - BioHarvest Sciences Inc (NASDAQ: BHST) (FSE: 8MV0), a...

Via Newsfile

Topics Artificial Intelligence

BioHarvest Sciences to Participate in the "Health, Wellness & Longevity" Virtual Conference Presented by Maxim Group LLC

July 13, 2026

Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - July 13, 2026) - BioHarvest Sciences Inc (NASDAQ: BHST) (FSE: 8MV0), a...

Via Newsfile

Topics Derivatives

Q2 Investor Summit Virtual Live Wednesday June 24

June 23, 2026

From Investor Summit Group

Via ACCESS Newswire

BioHarvest Sciences to Present at the 2026 BIO International Convention

June 18, 2026

Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - June 18, 2026) - BioHarvest Sciences Inc (NASDAQ: BHST) (FSE: 8MV0), a...

Via Newsfile

BioHarvest (BHST) Q4 2025 Earnings Transcript ↗

May 27, 2026

BioHarvest (BHST) Q4 2025 Earnings Transcript

Via The Motley Fool

BioHarvest (BHST) Q1 2026 Earnings Transcript ↗

May 18, 2026

BioHarvest (BHST) Q1 2026 Earnings Transcript

Via The Motley Fool

Tate & Lyle Expands Collaboration with BioHarvest Sciences to Accelerate Next-Generation Sweetener Innovation

May 18, 2026

Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - May 18, 2026) - BioHarvest Sciences Inc. (NASDAQ: BHST) (FSE: 8MV0), a...

Via Newsfile

BioHarvest Sciences Q1 Earnings Call Highlights ↗

May 14, 2026

BioHarvest Sciences (NASDAQ:BHST) reported higher first-quarter revenue and reiterated its 2026 outlook as management detailed a broader reorganization around two business lines: its direct-to-consumer...

Via MarketBeat

Topics Earnings

BioHarvest Sciences Reports First Quarter 2026 Financial Results and Provides Business Update

May 14, 2026

Quarterly revenue up 8% year over year; Annual revenue guidance range remains at $42-$48 million CDMO fragrance and Saffron...

Via Newsfile

BioHarvest Sciences Appoints New Head of Business Development for its CDMO Division

May 13, 2026

Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - May 13, 2026) - BioHarvest Sciences Inc. (NASDAQ: BHST) (FSE: 8MV0) ("BioHarvest"...

Via Newsfile

BioHarvest Sciences Announces Successful Completion of Stage 1 Development of Saffron Composition for Nutraceutical and Culinary Applications

May 13, 2026

- CDMO program advances to Stage 2 of development agreement valued at $1.125 million-Advancement of sustainable solution for the production...

Via Newsfile

Topics Economy

BioHarvest Sciences Signs $1.2M CDMO Stage 2 Contract for the Development of a Rare Fragrance Using Its Proprietary Botanical Synthesis Platform

May 12, 2026

Source plant is widely regarded as one of the most valuable fragrance raw materials in the worldStage 2 contract follows...

Via Newsfile

BioHarvest Sciences to Report First Quarter 2026 Financial Results on May 14, 2026

April 30, 2026

Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - April 30, 2026) - BioHarvest Sciences Inc. (NASDAQ: BHST) (FSE: 8MV0) ("BioHarvest"...

Via Newsfile

Topics Earnings

BioHarvest Sciences Announces Strategic Leadership Transition with Dr. Zaki Rakib Assuming Role of Chief Executive Officer to Accelerate "Two-Lens" Growth Strategy

April 29, 2026

Ilan Sobel joins Board of Directors with focused mandate on D2C growth.Dr. Zaki Rakib, Co-Founder and Executive Chairman, assumes role...

Via Newsfile

BioHarvest Sciences Reports Fourth Quarter and Full-Year 2025 Financial Results

March 31, 2026

FY2025 Revenues were $34.5 million, up 37% vs previous year.The VINIA brand has achieved the No.1 resveratrol polyphenol...

Via Newsfile

BioHarvest Sciences Announces First-Ever Successful Stable Cell Culture Development of Rare Fragrance-Producing Plant Using Proprietary Botanical Synthesis Platform

March 31, 2026

Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - March 31, 2026) - BioHarvest Sciences Inc. (NASDAQ: BHST) (FSE: 8MV0) ("BioHarvest"...

Via Newsfile

< Previous 1 2 3 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.